Issuu

Imaging in Heart Failure

10.

11.

12.

13.

14.

15.

16.

17.

o AS, Mozaffarian D, Roger VL, et al. Heart disease and G stroke statistics – 2014 update: a report from the American Heart Association. Circulation 2014;129:399–410. https://doi. org/10.1161/01.cir.0000442015.53336.12; PMID: 24446411. Marwick TH. Methods used for the assessment of LV systolic function: common currency or tower of Babel? Heart 2013;99:1078–86. https://doi.org/10.1136/ heartjnl-2012-303433; PMID: 23376947. Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016;37:2129–2200. https://doi.org/10.1093/eurheartj/ ehw128; PMID: 2720681. Lam CS, Solomon SD. The middle child in heart failure: heart failure with mid-range ejection fraction (40–50%). Eur J Heart Fail 2014;16:1049–55. https://doi.org/10.1002/ejhf.159; PMID: 25210008. Lam CS, Solomon SD. Fussing over the middle child: heart failure with mid-range ejection fraction. Circulation 2017;135:1279–80. https://doi.org/10.1161/ CIRCULATIONAHA.117.027324; PMID: 28373521. Solomon SD, Claggett B, Lewis EF, et al. Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction. Eur Heart J 2016;37:455–462. https://doi.org/10.1093/eurheartj/ ehv464; PMID: 26374849. Shah AM, Shah SJ, Anand IS, et al. Cardiac structure and function in heart failure with preserved ejection fraction: baseline findings from the echocardiographic study of the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial. Circ Heart Fail 2014;7:104–115. https://doi.org/10.1161/CIRCHEARTFAILURE.113.000887; PMID: 24249049. Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2016;29:277–314. https://doi.org/10.1016/j.echo.2016.01.011; PMID: 27037982. Edelmann F, Bobenko A, Gelbrich G, et al. Exercise training in diastolic heart failure (ex-DHF): rationale and design of a multicentre, prospective, randomized, controlled, parallel group trial. Eur J Heart Fail 2017;19:1067–74. https://doi. org/10.1002/ejhf.862; PMID: 28516519. Holland DJ, Prasad SB, Marwick TH. Prognostic implications of left ventricular filling pressure with exercise. Circ Cardiovasc Imaging 2010;3:149–56. https://doi.org/10.1161/ CIRCIMAGING.109.908152; PMID: 20233862. Lam CS, Roger VL, Rodeheffer RJ, et al. Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study. J Am Coll Cardiol 2009;53:1119–26. https://doi.org/10.1016/j.jacc.2008.11.051; PMID: 19324256. Park JJ, Park JB, Park JH, Cho GY. Global longitudinal strain to predict mortality in patients with acute heart failure. J Am Coll Cardiol. 2018;71(18):1947-1957. DeVore AD, McNulty S, Alenezi F, et al. Impaired left ventricular global longitudinal strain in patients with heart failure with preserved ejection fraction: insights from the RELAX trial. Eur J Heart Fail 2017;19:893–900. https://doi. org/10.1002/ejhf.754; PMID: 28194841. Hasselberg NE, Haugaa KH, Sarvari SI, et al. Left ventricular global longitudinal strain is associated with exercise capacity in failing hearts with preserved and reduced ejection fraction. Eur Heart J Cardiovasc Imaging 2015;16:217–24. https://doi. org/10.1093/ehjci/jeu277; PMID: 25552469. Habib G, Bucciarelli-Ducci C, Caforio ALP, et al. Multimodality imaging in restrictive cardiomyopathies: an EACVI expert consensus document. In collaboration with the ‘Working Group on myocardial and pericardial diseases’ of the European Society of Cardiology endorsed by the Indian Academy of Echocardiography. Eur Heart J Cardiovasc Imaging 2017;18:1090–121. https://doi.org/10.1093/ehjci/jex034; PMID: 28510718. Thavendiranathan P, Poulin F, Lim KD, et al. Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review. J Am Coll Cardiol 2014;63:2751–68. https://doi.org/10.1016/j.jacc.2014.01.073; PMID: 24703918. Charbonnel C, Convers-Domart R, Rigaudeau S, et al. Assessment of global longitudinal strain at low-dose anthracycline-based chemotherapy, for the prediction of subsequent cardiotoxicity. Eur Heart J Cardiovasc Imaging

C A R D I A C FA I L U R E R E V I E W

CFR_Grapsa_FINAL.indd 77

18.

19.

20.

21.

22.

23.

24.

25.

26.

27.

28.

29.

30.

31.

32.

33.

2017;18:392–401. https://doi.org/10.1093/ehjci/jew223; PMID: 28064155. von Roeder M, Rommel KP, Kowallick JT, et al. Influence of left atrial function on exercise capacity and left ventricular function in patients with heart failure and preserved ejection fraction. Circ Cardiovasc Imaging 2017;10:e005467. https://doi.org/10.1161/CIRCIMAGING.117.006785; PMID: 28790126. Tan TC, Koutsogeorgis ID, Grapsa J, et al. Left atrium and the imaging of atrial fibrosis: catch it if you can! Eur J Clin Invest 2014;44:872–81. https://doi.org/10.1111/eci.12305; PMID: 25066356. Grapsa J, Gibbs JS, Cabrita IZ, et al. The association of clinical outcome with right atrial and ventricular remodelling in patients with pulmonary arterial hypertension: study with real-time three-dimensional echocardiography. Eur Heart J Cardiovasc Imaging 2012;13:666–72. https://doi.org/10.1093/ ehjci/jes003; PMID: 22294683. Smith BC, Dobson G, Dawson D, et al. Three-dimensional speckle tracking of the right ventricle: toward optimal quantification of right ventricular dysfunction in pulmonary hypertension. J Am Coll Cardiol 2014;64:41–51. https://doi. org/10.1016/j.jacc.2014.01.084; PMID: 24998127. Le Polain de Waroux JB, Pouleur AC, Goffinet C, et al. Combined coronary and late-enhanced multidetector computed tomography for delineation of the etiology of left ventricular dysfunction: comparison with coronary angiography and contrast-enhanced cardiac magnetic resonance imaging. Eur Heart J 2008;29:2544–51. https://doi.org/10.1093/eurheartj/ehn381; PMID: 18762553. Winther S, Svensson M, Jørgensen HS, et al. Prognostic value of risk factors, calcium score, coronary CTA, myocardial perfusion imaging, and invasive coronary angiography in kidney transplantation candidates. JACC Cardiovasc Imaging 2018;11:842–54. https://doi.org/10.1016/j.jcmg.2017.07.012; PMID: 28917674. Behar JM, Rajani R, Pourmorteza A, et al. Comprehensive use of cardiac computed tomography to guide left ventricular lead placement in cardiac resynchronization therapy. Heart Rhythm 2017;14:1364–72. https://doi.org/10.1016/j. hrthm.2017.04.041; PMID: 2847951. Truong QA, Szymonifka J, Picard MH, et al. Utility of dualsource computed tomography in cardiac resynchronization therapy-DIRECT study. Heart Rhythm 2018. https://doi. org/10.1016/j.hrthm.2018.03.020; PMID: 29572087; epub ahead of print. Wang Y, Qin L, Shi X, et al. Adenosine-stress dynamic myocardial perfusion imaging with second-generation dualsource CT: comparison with conventional catheter coronary angiography and SPECT nuclear myocardial perfusion imaging. AJR Am J Roentgenol 2012;198:521–9. https://doi. org/10.2214/AJR.11.7830; PMID: 22357991. Bettencourt N, Chiribiri A, Schuster A, et al. Direct comparison of cardiac magnetic resonance and multidetector computed tomography stress-rest perfusion imaging for detection of coronary artery disease. J Am Coll Cardiol 2013;61:1099–107. https://doi.org/10.1016/ j.jacc.2012.12.020; PMID: 23375929. Meinel FG, Pugliese F, Schoepf UJ, et al. Prognostic value of stress dynamic myocardial perfusion CT in a multicenter population with known or suspected coronary artery disease. Am J Roentgenol 2017;208:761–9. https://doi.org/10.2214/ AJR.16.16186; PMID: 28177653. Nakanishi R, Budoff MJ. Noninvasive FFR derived from coronary CT angiography in the management of coronary artery disease: technology and clinical update. Vasc Health Risk Manag 2016;12:269–78. https://doi.org/10.2147/VHRM.S79632; PMID: 27382296. Lu MT, Ferencik MF, Roberts RS, et al. Noninvasive FFR derived from coronary CT angiography. Management and outcomes in the PROMISE trial. JACC Cardiovasc Imaging 2017;10:1350–8. https://doi.org/10.2147/VHRM.S79632; PMID: 27382296. Ang R, Hunter RJ, Baker V, et al. Pulmonary vein measurements on pre-procedural CT/MR imaging can predict difficult pulmonary vein isolation and phrenic nerve injury during cryoballoon ablation for paroxysmal atrial fibrillation. Int J Cardiol 2015;195:253–8. https://doi.org/10.1016/j. ijcard.2015.05.089; PMID: 26048388. Ismail TF, Cheasty E, King L, et al. High-pitch versus conventional cardiovascular CT in patients being assessed for transcatheter aortic valve implantation: a real-world appraisal. Open Heart 2017;4:e000626. https://doi.org/10.1136/ openhrt-2017-000626; PMID: 28878951. Nasis A, Mottram PM, Cameron JD, Seneviratne SK. Current and evolving clinical applications of multidetector cardiac CT in assessment of structural heart disease. Radiology 2013;267:11–25.

https://doi.org/10.1148/radiol.13111196; PMID: 23525715. 34. K urra V, Kapadia SR, Tuzcu EM, et al. Pre-procedural imaging of aortic root orientation and dimensions: comparison between X-ray angiographic planar imaging and 3-dimensional multidetector row computed tomography. JACC Cardiovasc Interv 2010;3:105–13. https://doi.org/10.1016/j. jcin.2009.10.014; PMID: 20129578. 35. Webb J, Fovargue L, Tøndel K, et al. The emerging role of cardiac magnetic resonance imaging in the evaluation of patients with HFpEF. Curr Heart Fail Rep 2018;15:1–9. https://doi.org/10.1007/s11897-018-0372-1; PMID: 29404975. 36. Su MY, Lin LY, Tseng YH, et al. CMR-verified diffuse myocardial fibrosis is associated with diastolic dysfunction in HFpEF. JACC Cardiovasc Imaging 2014;7:991–7. https://doi.org/10.1016/j. jcmg.2014.04.022; PMID: 25240451. 37. Rathi VK, Biederman RW. Expanding role of cardiovascular magnetic resonance in left and right ventricular diastolic function. Heart Fail Clin 2009;5:421–35. https://doi.org/10.1016/j. hfc.2009.02.005; PMID: 19564017. 38. Azarisman SM, Carbone A, Shirazi M, et al. Characterisation of myocardial injury via T1 mapping in early reperfused myocardial infarction and its relationship with global and regional diastolic dysfunction. Heart Lung Circ 2016;25:1094–106. https://doi.org/10.1016/j.hlc.2016.03.011; PMID: 27210302. 39. Le TT, Huang W, Bryant JA, et al. Stress cardiovascular magnetic resonance imaging: current and future perspectives. Expert Rev Cardiovasc Ther 2017;15:181–89. https://doi.org/10.108 0/14779072.2017.1296356; PMID: 28256176. 40. Pontone G, Andreini D, Guaricci AI, et al. The STRATEGY study (stress cardiac magnetic resonance versus computed tomography coronary angiography for the management of symptomatic revascularized patients): resources and outcomes impact. Circ Cardiovasc Imaging 2016;9:e005171. https://doi. org/10.1161/CIRCIMAGING.116.005171; PMID: 27894070. 41. Child NM, Das R. Is cardiac magnetic resonance imaging assessment of myocardial viability useful for predicting which patients with impaired ventricles might benefit from revascularization? Interact Cardiovasc Thorac Surg 2012;14:395–8. https://doi.org/10.1093/icvts/ivr161; PMID: 22279116. 42. Halliday BP, Cleland JGF, Goldberger JJ, Prasad SK. Personalizing risk stratification for sudden death in dilated cardiomyopathy: the past, present, and future. Circulation 2017;136:215–31. https://doi.org/10.1161/ CIRCULATIONAHA.116.027134; PMID: 28696268. 43. Wei S, Fu J, Chen L, Yu S. Performance of cardiac magnetic resonance imaging for diagnosis of myocarditis compared with endomyocardial biopsy: a meta-analysis. Med Sci Monit 2017;23:3687–96. https://doi.org/10.12659/MSM.902155; PMID: 28755532. 44. Mayr A, Klug G, Feistritzer HJ, et al. Myocardial edema in acute myocarditis: relationship of T2 relaxometry and late enhancement burden by using dual-contrast turbo spinecho MRI. Int J Cardiovasc Imaging 2017;33:1789–94. https://doi. org/10.1007/s10554-017-1170-7; PMID: 28528429. 45. Gaikwad N, Butler T, Maxwell R, et al. Late gadolinium enhancement does occur in Tako-tsubo cardiomyopathy – a quantitative cardiac magnetic resonance and speckle tracking strain study. Int J Cardiol Heart Vasc 2016;12:68–74. https://doi.org/10.1016/j.ijcha.2016.07.009; PMID: 28616546. 46. Tomaselli GF, Zipes DP. What causes sudden death in heart failure? Circ Res 2004;95:754–63. https://doi.org/10.1161/01. RES.0000145047.14691.db; PMID: 15486322. 47. Buxton AE, Lee KL, Hafley GE, et al. Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study. J Am Coll Cardiol 2007;50:1150–7. https://doi.org/10.1016/j. jacc.2007.04.095; PMID: 17868806. 48. Taqueti VR, Solomon SD, Shah AM, et al. Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction. Eur Heart J 2017;39:840–9. https://doi.org/10.1093/eurheartj/ehx721; PMID: 29293969. 49. Gaemperli O, Kaufmann PA, Alkadhi H. Cardiac hybrid imaging. Eur J Nucl Med Mol Imaging 2014;41:S91–103. https://doi. org/10.1007/s00259-013-2566-9; PMID: 24658682. 50. Truong QA, Gewirtz H. Cardiac PET-CT for monitoring medical and interventional therapy in patients with CAD: PET alone versus hybrid PET-CT? Curr Cardiol Rep 2014;16:460. https://doi. org/10.1007/s11886-013-0460-5; PMID: 24464305. 51. Qian Z, Wang K, Liu S, et al. Quantitative prediction of paravalvular leak in transcatheter aortic valve replacement based on tissue-mimicking 3D printing. JACC Cardiovasc Imaging 2017;10:719–31. https://doi.org/10.1016/j.jcmg.2017.04.005; PMID: 28683947.

13/08/2018 22:13